Institute of Cancer Science - Beatson West of Scotland Cancer Centre

Glasgow 1053

0 studies enrolling now · 1 studies all time

What they study most

HNSCC

Studies at this site

• Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC — Completed